[1]
Yan Yan, Yong Ren, Renfang Chen, Jing Hu, Yongjia Ji, Junyang Yang, Jiayin Shen, Lvyin Hu, Hao Pei, Jun Wang, Yuanwang Qiu, Hongzhou Lu, Lihua Huang, 2018: Evaluation of Epstein-Barr Virus Salivary Shedding in HIV/AIDS Patients and HAART Use: A Retrospective Cohort Study, Virologica Sinica, 33, 227-233. doi: 10.1007/s12250-018-0028-z
[2]
Yi ZENG, 2007: Strategy for AIDS Prevention and Treatment, Virologica Sinica, 22, 419-420.
[3]
Yi-ming SHAO, 2007: AIDS Research and Its Role in China's AIDS Prevention and Control Policies, Virologica Sinica, 22, 421-423.
[4]
蒋岩, 1997: Research advances of animal models of murine AIDS for evaluation of anti - AIDS treatment, Virologica Sinica, 12, 1-.
[5]
刘强, 杨贵波, 邵一鸣*, 2006: SHIV Construction and Application in the AIDS Vaccine and Drug Research, Virologica Sinica, 21, 523-527.
[6]
吴颖运, 洪坤学, 耿运琪, 邵一鸣, 2004: The Application of Live Attenuated SHIV in AIDS Vaccine Research, Virologica Sinica, 19, 187-191.
[7]
Xiao-Jie Li, Rie Uenishi, Saiki Hase, Huanan Liao, Tee Kok Keng, Shigeru Kusagawa, Yutaka Takebe, 2007: HIV/AIDS in Asia: The Shape of Epidemics and Their Molecular Epidemiology, Virologica Sinica, 22, 424-433.
[8]
Wen-yuan YIN, Zun-you WU, 2007: Challenges and Opportunities: the Expanded Government-led HIV/AIDS Programs in China, Virologica Sinica, 22, 493-500.
[9]
张颖*, 白雪帆, 黄长形, 白宪光, 2004: HIV-1 Coreceptors and Coreceptor-related AIDS Therapy, Virologica Sinica, 19, 182-186.
[10]
Jian WANG, Wen ZOU, 2007: A General Introduction of HIV/AIDS Treatment with Traditional Chinese Medicine in China, Virologica Sinica, 22, 471-475.
[11]
Leonard J.Rosenthal, Stephen M.Peters, Abdur Razzaque, 1988: Analysis of AIDS KS Biopsy and Peripheral Blood Lymphocyte Specimens for Human Cytomegalovirus Transforming DNA Sequences, Virologica Sinica, 3, 317-.
[12]
Ming-hua LI, Shao-you LI, Hou-jun XIA, Lu WANG, Yuan-yuan WANG, Gao-hong ZHANG, Yong-tang ZHENG, 2007: Establishment of AIDS Animal Model with SIVmac239 Infected Chinese Rhesus Monkey, Virologica Sinica, 22, 509-516.
[13]
Zhihao Zhang, Wei Hou, Shuliang Chen, 2022: Updates on CRISPR-based gene editing in HIV-1/AIDS therapy, Virologica Sinica, 37, 1-10. doi: 10.1016/j.virs.2022.01.017
[14]
郑永唐, 贲昆龙, 王金焕, 齐瑾, 黄生民, 1997: Establishment and application of an experimental model for screening anti - AIDS drugs with simian type D retrovirus, Virologica Sinica, 12, 61-.
[15]
Chang LI, Qin-xue HU, 2009: Driving Forces of AIDS Pathogenesis: Massive CD4⁺ T Lymphocyte Depletion and Abnormal Immune Activation, Virologica Sinica, 24, 501-508. doi: 10.1007/s12250-009-3063-y
[16]
文建凡, 黄生民, 郑永唐, 1999: The Assem bly and Release of Sim ian AIDS Type D Retrovirus （SRV)：Involvement of Intermediate Filament, Virologica Sinica, 14, 231-235.
[17]
Kun-xue HONG, Xiao-zhi LU, Guang-ming QIN, Jian-ping CHEN, Yu-hua RUAN, Hui XING, Jia-hong ZHU, Yi-ming SHAO, 2007: Relationship of HLA-A, -Cw Polymorphisms with HIV/AIDS in Chinese Yi Ethnic Group of Sichuan Province^*, Virologica Sinica, 22, 301-306.
[18]
Zhihao Zhang, Wei Hou, Shuliang Chen, 0: Updates on CRISPR-based gene editing in HIV-1/AIDS therapy, Virologica Sinica.
[19]
Yan JIANG, 2007: Development and Challenge of HIV/AIDS Testing Laboratory Network and Quality Assurance System in China, Virologica Sinica, 22, 434-442.
[20]
李明远, 1989: Virus Infections and Virus Receptors, Virologica Sinica, 4, 219-.